Northwestern Medicine scientists have developed a new way to image chromatin within living cells, opening the door to large-scale screening techniques, including for cancer.
Browsing: Cancer
Northwestern Medicine scientists identified an enzyme as a potential new target for triple-negative breast cancer, a form of breast cancer that is associated with early tumor recurrence and significantly increased mortality rates.
Northwestern Medicine scientists have identified a protein that acts as a marker for a population of cells that may be an origin for prostate cancers.
Internationally renowned Swiss neuro-oncologist Roger Stupp, MD, will join Northwestern Medicine as a professor of Neurological Surgery.
Northwestern Medicine scientists have identified a signaling pathway that regulates the behavior of two subtypes of glioblastomas.
Dai Horiuchi, PhD, assistant professor of Pharmacology, has been awarded a $450,000 research grant from Susan G. Komen to explore a potential targeted therapy against triple-negative breast cancer.
This year, the University launched a new Center for Synthetic Biology, making Northwestern one of the top three U.S. destinations for research and education in this area.
An expert panel led by Northwestern Medicine investigator Judith Paice, PhD, RN, developed recommendations to help clinicians manage the chronic pain of cancer survivors.
Faculty from the Division of Hematology/Oncology presented a panel discussion on lymphoma research, treatment and novel trials.
New Northwestern Medicine research has shown that reprogrammed stem cells can be used to identify patients with cancer who are likely to experience a dangerous side effect of a common chemotherapy drug.